project id: TCGA-LIHC; case submitter id: TCGA-LG-A9QC; analyte type: DNA; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.99; rna integrity number: 9.4; age at index: 48; days to birth: -17842; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1965; age at diagnosis: 17842; ajcc pathologic m: M0; ajcc pathologic n: NX; ajcc pathologic stage: Stage I; ajcc pathologic t: T1; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 425.0; icd 10 code: C22.0; last known disease status: not reported; morphology: 8170/3; primary diagnosis: Hepatocellular carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Liver; synchronous malignancy: No; tissue or organ of origin: Liver; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 62; days to sample procurement: 0; initial weight: 1080.0; portion submitter id: TCGA-LG-A9QC-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 1.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 4.0; percent tumor cells: 95.0; percent tumor nuclei: 97.0;